Oral Phage Therapy of Acute Bacterial Diarrhea With Two Coliphage Preparations: A Randomized Trial in Children From Bangladesh

EBioMedicine

Volumn 4, Issue , 2016, Pages 124-137

  Sarker, Shafiqul Alam ^a   Sultana, Shamima ^a   Reuteler, Gloria ^b   Moine, Deborah ^b   Descombes, Patrick ^b   Charton, Florence ^b   Bourdin, Gilles ^b   McCallin, Shawna ^b   Ngom Bru, Catherine ^b   Neville, Tara ^b   Akter, Mahmuda ^a   Huq, Sayeeda ^a   Qadri, Firdausi ^a   Talukdar, Kaisar ^a   Kassam, Mohamed ^b   Delley, Michèle ^b   Loiseau, Chloe ^b   Deng, Ying ^b   El Aidy, Sahar ^b   Berger, Bernard ^b   Brüssow, Harald ^b   more..

^a INTERNATIONAL CENTRE FOR DIARRHOEAL DISEASE RESEARCH   (Bangladesh)

^b NESTLÉ RESEARCH CENTER   (Switzerland)

Author keywords

Bacteriophages; Bangladesh; Bifidobacterium; Children; Diarrhea; Escherichia coli; Streptococcus

Indexed keywords

ORAL REHYDRATION SOLUTION;

ACUTE DIARRHEA; ARTICLE; BACTERIAL OVERGROWTH; BACTERIUM COLONY; BANGLADESH; BIFIDOBACTERIUM; CHILD; COLIPHAGE; CONTROLLED STUDY; ENTEROBACTERIA PHAGE T4; ENTEROTOXIGENIC ESCHERICHIA COLI; ENZYME LINKED IMMUNOSORBENT ASSAY; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTION; FECES; FECES CULTURE; FECES MICROFLORA; GENE SEQUENCE; GENOMICS; HUMAN; MAJOR CLINICAL STUDY; MICROBIAL COMMUNITY; MICROSCOPY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STREPTOCOCCUS; STREPTOCOCCUS GALLOLYTICUS; STREPTOCOCCUS SALIVARIUS; ADOLESCENT; DIARRHEA; ENTEROPATHOGENIC ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; FEMALE; MALE; MICROBIOLOGY; ORAL DRUG ADMINISTRATION; PATHOGENICITY; PHAGE THERAPY; VIROLOGY;

ADMINISTRATION, ORAL; ADOLESCENT; BANGLADESH; CHILD; COLIPHAGES; DIARRHEA; ENTEROPATHOGENIC ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; FEMALE; HUMANS; MALE; PHAGE THERAPY;

EID: 84953807252     PISSN: None     EISSN: 23523964     Source Type: Journal    
DOI: 10.1016/j.ebiom.2015.12.023     Document Type: Article

References (66)

1. Ahmed, T., Bhuiyan, T.R., Zaman, K., Sinclair, D., Qadri, F., Vaccines for preventing enterotoxigenic Escherichia coli (ETEC) diarrhoea. Cochrane Database Syst. Rev., 7, 2013, CD009029.
2. Albert, M.J., Faruque, A.S., Faruque, S.M., Sack, R.B., Mahalanabis, D., Case–control study of enteropathogens associated with childhood diarrhea in Dhaka, Bangladesh. J. Clin. Microbiol. 37 (1999), 3458–3464.
3. Allen, H.K., Looft, T., Bayles, D.O., et al. Antibiotics in feed induce prophages in swine fecal microbiomes. MBio, 2, 2011, e00260–11.
4. Altschul, S.F., Gish, W., Miller, W., et al. Basic local alignment search tool. J. Mol. Biol. 215 (1990), 403–410.
5. Barletta, F., Ochoa, T.J., Mercado, E., et al. Quantitative real-time polymerase chain reaction for enteropathogenic Escherichia coli: a tool for investigation of asymptomatic versus symptomatic infections. Clin. Infect. Dis. 53 (2011), 1223–1229.
6. Boleij, A., Tjalsma, H., The itinerary of Streptococcus gallolyticus infection in patients with colonic malignant disease. Lancet Infect. Dis. 13:8 (2013), 719–724.
7. Booijink, C.C., et al. High temporal and inter-individual variation detected in the human ileal microbiota. Environ. Microbiol. 12:12 (2010), 3213–3227.
8. Bourdin, G., Navarro, A., Sarker, S.A., et al. Coverage of diarrhoea-associated Escherichia coli isolates from different origins with two types of phage cocktails. Microb. Biotechnol. 7 (2014), 165–176.
9. Bourdin, G., Schmitt, B., Marvin Guy, L., et al. Amplification and purification of T4-like Escherichia coli phages for phage therapy: from laboratory to pilot scale. Appl. Environ. Microbiol. 80 (2014), 1469–1476.
10. Brüssow, H., Phage therapy: the Escherichia coli experience. Microbiology 151 (2005), 2133–2140.
11. Brüssow, H., What is needed for phage therapy to become a reality in Western medicine?. Virology 434 (2012), 138–142.
12. Brüssow, H., Bacteriophage–host interaction: from splendid isolation into a messy reality. Curr. Opin. Microbiol. 16 (2013), 500–506.
13. Bruttin, A., Brüssow, H., Human volunteers receiving Escherichia coli phage T4 orally: a safety test of phage therapy. Antimicrob. Agents Chemother. 49 (2005), 2874–2878.
14. Caporaso, J.G., et al. QIIME allows analysis of high-throughput community sequencing data. Nat. Methods 7 (2010), 335–336.
15. Casswall, T.H., Sarker, S.A., Faruque, S.M., et al. Treatment of enterotoxigenic and enteropathogenic Escherichia coli-induced diarrhoea in children with bovine immunoglobulin milk concentrate from hyperimmunized cows: a double-blind, placebo-controlled, clinical trial. Scand. J. Gastroenterol. 35 (2000), 711–718.
16. Chen, L., Xiong, Z., Sun, L., Yang, J., Jin, Q., VFDB 2012 update: toward the genetic diversity and molecular evolution of bacterial virulence factors. Nucleic Acids Res. 40:Database issue (2012), D641–D645.
17. Chibani-Chennoufi, S., Sidoti, J., Bruttin, A., et al. Isolation of Escherichia coli bacteriophages from the stool of pediatric diarrhea patients in Bangladesh. J. Bacteriol. 186 (2004), 8287–8294.
18. Chin, C.S., et al. Nonhybrid, finished microbial genome assemblies from long-read SMRT sequencing data. Nat. Methods 10:6 (2013), 563–569.
19. Collins, J.W., Keeney, K.M., Crepin, V.F., et al. Citrobacter rodentium: infection, inflammation and the microbiota. Nat. Rev. Microbiol. 12 (2014), 612–623.
20. Danne, C., et al. Molecular characterization of a Streptococcus gallolyticus genomic island encoding a pilus involved in endocarditis. J. Infect. Dis. 204 (2011), 1960–1970.
21. David, L.A., et al. Gut microbial succession follows acute secretory diarrhea in humans. MBio, 6(3), 2015, e00381–15.
22. Denou, E., Bruttin, A., Barretto, C., Ngom-Bru, C., Brüssow, H., Zuber, S., T4 phages against Escherichia coli diarrhea: potential and problems. Virology 388 (2009), 21–30.
23. Ding, T., Schloss, P.D., Dynamics and associations of microbial community types across the human body. Nature 509 (2014), 357–360.
24. Edgar, R.C., Search and clustering orders of magnitude faster than BLAST. Bioinformatics 26 (2010), 2460–2461.
25. Edgar, R.C., Haas, B.J., Clemente, J.C., Quince, C., Knight, R., UCHIME improves sensitivity and speed of chimera detection. Bioinformatics 27 (2011), 2194–2200.
26. Fairbrother, J.M., Nadeau, E., Gyles, C.L., Escherichia coli in postweaning diarrhea in pigs: an update on bacterial types, pathogenesis, and prevention strategies. Anim. Health Res. Rev. 6 (2005), 17–39.
27. Gardner, S.N., Hall, B.G., When whole-genome alignments just won't work: kSNP v2 software for alignment-free SNP discovery and phylogenetics of hundreds of microbial genomes. PLoS One, 8(12), 2013, e81760 (2013 Dec 9).
28. Goldsmith, C.S., Miller, S.E., Modern use of electron microscopy for detection of viruses. Clin. Microbiol. Rev. 22 (2009), 552–563.
29. Guion, C.E., Ochoa, T.J., Walker, C.M., Barletta, F., Cleary, T.G., Detection of diarrheagenic Escherichia coli by use of melting-curve analysis and real-time multiplex PCR. J. Clin. Microbiol. 46 (2008), 1752–1757.
30. Guzmán, C., Mocé-Llivina, L., Lucena, F., Jofre, J., Evaluation of Escherichia coli host strain CB390 for simultaneous detection of somatic and F-specific coliphages. Appl. Environ. Microbiol. 74 (2008), 531–534.
31. Harris, A.M., Chowdhury, F., Begum, Y.A., et al. Shifting prevalence of major diarrheal pathogens in patients seeking hospital care during floods in 1998, 2004, and 2007 in Dhaka, Bangladesh. Am.J.Trop. Med. Hyg. 79 (2008), 708–714.
32. Hilpert, H., Brüssow, H., Mietens, C., Sidoti, J., Lerner, L., Werchau, H., Use of bovine milk concentrate containing antibody to rotavirus to treat rotavirus gastroenteritis in infants. J. Infect. Dis. 156 (1987), 158–166.
33. Holmes, I., Harris, K., Quince, C., Dirichlet multinomial mixtures: generative models for microbial metagenomics. PLoS One, 7, 2012, e30126.
34. Hsiao, A., Ahmed, A.M., Subramanian, S., et al. Members of the human gut microbiota involved in recovery from Vibrio cholerae infection. Nature 515 (2014), 423–426.
35. Jiang, Z.D., Lowe, B., Verenkar, M.P., et al. Prevalence of enteric pathogens among international travelers with diarrhea acquired in Kenya (Mombasa), India (Goa), or Jamaica (Montego Bay). J. Infect. Dis. 185 (2002), 497–502.
36. Jin, D., et al. Dynamics of fecal microbial communities in children with diarrhea of unknown etiology and genomic analysis of associated Streptococcus lutetiensis. BMC Microbiol., 13, 2013, e141.
37. Junick, J., Blaut, M., Quantification of human fecal bifidobacterium species by use of quantitative real-time PCR analysis targeting the groEL gene. Appl. Environ. Microbiol. 78 (2012), 2613–2622.
38. Kotloff, K.L., Nataro, J.P., Blackwelder, W.C., et al. Burden and aetiology of diarrhoeal disease in infants and young children in developing countries (the Global Enteric Multicenter Study, GEMS): a prospective, case–control study. Lancet 382 (2013), 209–222.
39. Liu, B., Pop, M., ARDB—antibiotic resistance genes database. Nucleic Acids Res. 37:Database issue (2009), D443–D447 (2009 Jan).
40. Liu, J., Kabir, F., Manneh, J., et al. Development and assessment of molecular diagnostic tests for 15 enteropathogens causing childhood diarrhoea: a multicentre study. Lancet Infect. Dis. 14 (2014), 716–724.
41. Martinez, L., The evolving threat of antimicrobial resistance. Options for Action, 2012, WHO, Geneva.
42. McCallin, S., Sarker, S.A., Barretto, C., et al. Safety analysis of a Russian phage cocktail: from MetaGenomic analysis to oral application in healthy human subjects. Virology 443 (2013), 187–196.
43. Międzybrodzki, R., Borysowski, J., Weber-Dąbrowska, B., et al. Clinical aspects of phage therapy. Adv. Virus Res. 83 (2012), 73–121.
44. Nadkarni, M.A., Martin, F.E., Jacques, N.A., Hunter, N., Determination of bacterial load by real-time PCR using a broad-range (universal) probe and primers set. Microbiology 148 (2002), 257–266.
45. Piddock, L.J., The crisis of no new antibiotics—what is the way forward?. Lancet Infect. Dis. 12 (2012), 249–253.
46. Pop, M., et al. Diarrhea in young children from low-income countries leads to large-scale alterations in intestinal microbiota composition. Genome Biol., 15(6), 2014, R76.
47. Qadri, F., Svennerholm, A.M., Faruque, A.S., Sack, R.B., Enterotoxigenic Escherichia coli in developing countries: epidemiology, microbiology, clinical features, treatment, and prevention. Clin. Microbiol. Rev. 18 (2005), 465–483.
48. Quince, C., et al. Accurate determination of microbial diversity from 454 pyrosequencing data. Nat. Methods 6 (2009), 639–641.
49. Sanchez, M., Darimont, C., Drapeau, V., et al. Effect of Lactobacillus rhamnosus CGMCC1.3724 supplementation on weight loss and maintenance in obese men and women. Br. J. Nutr. 111 (2014), 1507–1519.
50. Sarker, S.A., Casswall, T.H., Mahalanabis, D., et al. Successful treatment of rotavirus diarrhea in children with immunoglobulin from immunized bovine colostrum. Pediatr. Infect. Dis. J. 17 (1998), 1149–1154.
51. Sarker, S.A., McCallin, S., Barretto, C., et al. Oral T4-like phage cocktail application to healthy adult volunteers from Bangladesh. Virology 434 (2012), 222–232.
52. Sarker, S.A., Sultana, S., Fuchs, G.J., et al. Lactobacillus paracasei strain ST11 has no effect on rotavirus but ameliorates the outcome of nonrotavirus diarrhea in children from Bangladesh. Pediatrics 116 (2005), e221–e228.
53. Schlegel, L., Grimont, F., Ageron, E., Grimont, P.A., Bouvet, A., Reappraisal of the taxonomy of the Streptococcus bovis/Streptococcus equinus complex and related species: description of Streptococcus gallolyticus subsp. gallolyticus subsp. nov., S. gallolyticus subsp. macedonicus subsp. nov. and S. gallolyticus subsp. pasteurianus subsp. nov. Int. J. Syst. Evol. Microbiol. 53:Pt 3 (2003), 631–645.
54. Schloss, P.D., Westcott, S.L., Assessing and improving methods used in operational taxonomic unit-based approaches for 16S rRNA gene sequence analysis. Appl. Environ. Microbiol. 77 (2011), 3219–3226.
55. Schloss, P.D., et al. Introducing mothur: open-source, platform-independent, community-supported software for describing and comparing microbial communities. Appl. Environ. Microbiol. 75 (2009), 7537–7541.
56. Simeoni, U., Berger, B., Junick, J., et al. Gut microbiota analysis reveals a marked shift to bifidobacteria by a starter infant formula containing a synbiotic of bovine milk-derived oligosaccharides and Bifidobacterium animalis subsp. lactis CNCM I-3446. Environ. Microbiol., 2015, 10.1111/1462-2920.13144 (Epub ahead of print).
57. Stanton, T.B., A call for antibiotic alternatives research. Trends Microbiol. 21 (2013), 111–113.
58. Sulakvelidze, A., Alavidze, Z., Morris, J.G. Jr., Bacteriophage therapy. Antimicrob. Agents Chemother. 45 (2001), 649–659.
59. Svenungsson, B., Lagergren, A., Ekwall, E., et al. Enteropathogens in adult patients with diarrhea and healthy control subjects: a 1-year prospective study in a Swedish clinic for infectious diseases. Clin. Infect. Dis. 30 (2000), 770–778.
60. Taniuchi, M., Sobuz, S.U., Begum, S., et al. Etiology of diarrhea in Bangladeshi infants in the first year of life analyzed using molecular methods. J. Infect. Dis. 208 (2013), 1794–1802.
61. Van den Bogert, B., Boekhorst, J., Herrmann, R., Smid, E.J., Zoetendal, E.G., Kleerebezem, M., Comparative genomics analysis of Streptococcus isolates from the human small intestine reveals their adaptation to a highly dynamic ecosystem. PLoS One, 8(12), 2013, e83418.
62. Vidal, M., Kruger, E., Durán, C., et al. Single multiplex PCR assay to identify simultaneously the six categories of diarrheagenic Escherichia coli associated with enteric infections. J. Clin. Microbiol. 43 (2005), 5362–5365.
63. Weiss, M., Denou, E., Bruttin, A., Serra-Moreno, R., Dillmann, M.L., Brüssow, H., In vivo replication of T4 and T7 bacteriophages in germ-free mice colonized with Escherichia coli. Virology 393 (2009), 16–23.
64. Wiggins, B.A., Alexander, M., Minimum bacterial density for bacteriophage replication: implications for significance of bacteriophages in natural ecosystems. Appl. Environ. Microbiol. 49 (1985), 19–23.
65. Wright, A., Hawkins, C.H., Anggård, E.E., Harper, D.R., A controlled clinical trial of a therapeutic bacteriophage preparation in chronic otitis due to antibiotic-resistant Pseudomonas aeruginosa; a preliminary report of efficacy. Clin. Otolaryngol. 34 (2009), 349–357.
66. Yang, C.J., Lee, N.Y., Lin, Y.H., et al. Jarisch–Herxheimer reaction after penicillin therapy among patients with syphilis in the era of the HIV infection epidemic: incidence and risk factors. Clin. Infect. Dis. 51 (2010), 976–979.